pharmadog
the cliff

Patent cliff

Drugs ranked by the soonest barrier to generic / biosimilar entry. Each row shows the earliest-expiring patent OR FDA exclusivity for that drug — whichever falls first determines when competitive pressure begins.

window< 2 years< 5 years< 10 yearsall future884 drugs
← prevpage 18 of 18next →
sourced from FDA Orange Book · approved drugs only · biologics + biosimilars excluded (those live in the Purple Book — coming soon)